Combination Drug Development Incentive Act of 2015

Summary

Combination Drug Development Incentive Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to provide a five-year marketing exclusivity period to a new drug approved by the Food and Drug Administration that is a novel combination of active ingredients. The application for the combination drug must contain reports of new clinical investigations that are essential to approval and were conducted or sponsored by the applicant. Currently, a new drug that includes an active ingredient that has already been approved is provided a three-year marketing exclusivity period.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 20 January 2015

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 20 January 2015

   Introduced

   Introduced in House

   Source: IntroReferral

3. 20 January 2015

   Introduced

   Introduced in House

   Source: IntroReferral

4. 23 January 2015

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 20 January 2015 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 20 January 2015

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 20 January 2015

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 20 January 2015

  Open at official source

Sponsors

• Jason Chaffetz · R · Sponsor
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.